Elevated plasma levels of TIMP-1 correlate with plasma suPAR/uPA in patients with chronic myeloproliferative disorders-Reference-Cited by-同舟云学术

Elevated plasma levels of TIMP-1 correlate with plasma suPAR/uPA in patients with chronic myeloproliferative disorders

Published:2003-10-09 Issue:5 Volume:71 Page:377-384
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Jensen Morten Krogh,Holten-Andersen Mads Nikolaj,Riisbro Rikke,de Nully Brown Peter,Larsen Maj Britt,Kjeldsen Lars,Heickendorff Lene,Brünner Nils,Hasselbalch Hans Carl

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1034/j.1600-0609.2003.00096.x/fullpdf

Reference42 articles.

1. Regulatory mechanisms controlling hematopoiesis: principles and problems;Metcalf;Stem Cells (Dayt),1998

2. Role of bone marrow matrix in normal and abnormal hematopoiesis;Verfaillie;Crit Rev Oncol Hematol,1994

3. Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia;Le Bousse-Kerdilès;Springer Semin Immunopathol,2000

4. Evaluation and clinical correlations of bone marrow angiogensis in myelofibrosis with myeloid metaplasia;Mesa;Blood,2000

5. Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis;Le Bousse-Kerdilès;Ann Hematol,1999

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms;Cancers;2023-08-29

2. A Broad Overview of Signaling in Ph-Negative Classic Myeloproliferative Neoplasms;Cancers;2021-02-26

3. Expression profile analysis reveals hub genes that are associated with immune system dysregulation in primary myelofibrosis;Hematology;2021-01-01

4. Monocytes with Oncogenic Mutation JAK2 V617F as a Tool for Studies of the Pathogenic Mechanisms of Myelofibrosis;Bulletin of Experimental Biology and Medicine;2018-03

5. Matrix Metalloproteinases 2 and 9 Polymorphism in Patients With Myeloproliferative Diseases A STROBE-Compliant Observational Study;MEDICINE;2015